Dual‐targeting immunoliposomes using angiopep‐2 and CD133 antibody for glioblastoma stem cells

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Controlled Release

• Publication date

  2018-01-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jconrel.2017.11.026PMID 29162480
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nanoparticles: Novel vehicles in treatment of Glioblastoma.

  2016cited by this paper
• Synergistic Effect of Immunoliposomal Gemcitabine and Bevacizumab in Glioblastoma Stem Cell-Targeted Therapy.

  2015cited by this paper
• The PD-1/B7-H1 Pathway Modulates the Natural Killer Cells versus Mouse Glioma Stem Cells

  2015cited by this paper
• TEER Measurement Techniques for In Vitro Barrier Model Systems

  2015cited by this paper
• LRP-1-mediated intracellular antibody delivery to the Central Nervous System

  2015cited by this paper
• Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells

  2014cited by this paper
• Angiopep-2-conjugated liposomes encapsulating γ-secretase inhibitor for targeting glioblastoma stem cells

  2014cited by this paper
• Nanoparticles for hyperthermic therapy: synthesis strategies and applications in glioblastoma

  2014cited by this paper
• Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.

  2014cited by this paper
• CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges

  2013cited by this paper
• The value of temozolomide in combination with radiotherapy during standard treatment for newly diagnosed glioblastoma

  2013cited by this paper
• Understanding and targeting cancer stem cells: therapeutic implications and challenges

  2013cited by this paper
• Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment

  2013cited by this paper
• A New 2-Pyrone Derivative, 5-Bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, Suppresses Stemness in Glioma Stem-Like Cells

  2012cited by this paper
• Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.

  2012cited by this paper
• The impact of enrollment in clinical trials on survival of patients with glioblastoma.

  2012cited by this paper
• PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors.

  2011cited by this paper
• Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells

  2011cited by this paper
• Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.

  2011cited by this paper
• Glioblastoma therapy: going beyond Hercules Columns

  2010cited by this paper
• Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8

  2010cited by this paper
• Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas

  2010cited by this paper
• Exciting New Advances in Neuro‐Oncology: The Avenue to a Cure for Malignant Glioma

  2010cited by this paper
• Current data and strategy in glioblastoma multiforme

  2009cited by this paper
• Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors

  2009cited by this paper
• Identification and Design of Peptides as a New Drug Delivery System for the Brain

  2008cited by this paper
• Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87.

  2008cited by this paper
• Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel.

  2007cited by this paper
• Neurological Disorders: Public Health Challenges

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Malignant astrocytic glioma: genetics, biology, and paths to treatment.

  2007cited by this paper
• Pericytes from Brain Microvessels Strengthen the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells

  2007cited by this paper
• Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.

  2007cited by this paper
• Angiogenesis in brain tumours

  2007cited by this paper
• Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor.

  2006cited by this paper
• Drug delivery to brain tumours: challenges and progress

  2006cited by this paper
• Projections of Global Mortality and Burden of Disease from 2002 to 2030

  2006cited by this paper
• Neural stem cells and the origin of gliomas.

  2005cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Molecular mechanisms of glioma invasiveness: the role of proteases

  2003cited by this paper
• The use of temozolomide in recurrent malignant gliomas.

  2002cited by this paper
• Stem cells, cancer, and cancer stem cells

  2001cited by this paper
• The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery.

  2000cited by this paper
• Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

  2000cited by this paper
• Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein.

  2000cited by this paper
• RESPONSE: Re: Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality.

  1999cited by this paper
• Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality.

  1999cited by this paper
• Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

  1997cited by this paper
• Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas.

  1997cited by this paper

• Advances and Challenges in Nano-Delivery Systems for Glioblastoma Treatment: A Comprehensive Review

  2025cites this paper
• Advancements in Liposomal Drug Delivery Systems for Paediatric Neurological Disorders: A Comprehensive Review

  2025influential citation
• Design and Evaluation of the PLGA Nanoparticles Containing Ketorolac Tromethamine in Glioblastoma Treatment

  2025cites this paper
• Overcoming the blood-brain barrier challenge: nanotechnology-enhanced photodynamic therapy for glioblastoma treatment.

  2025cites this paper
• Liposomes and Extracellular Vesicles as Distinct Paths Toward Precision Glioma Treatment

  2025influential citation
• Aggregation-Induced Emission Active Copolymers Designed for Stabilizing Cubic Phase Lipid Nanoparticles That Can Be Used for Bioimaging.

  2025cites this paper
• Advances in CNS drug delivery strategies to cross the blood-brain barrier

  2025cites this paper
• Utilization of universal-targeting mSA2 CAR-T cells for the treatment of glioblastoma

  2025cites this paper
• Research Progress on Surface Markers of Glioma Cancer Stem Cells and Related Targeted Therapeutic Strategies

  2025cites this paper
• Glioma stem cells: drivers of tumor progression and recurrence

  2025cites this paper
• Microinvasive Deployment and Fate-Determination of Functional, Engineered Nanoparticles in Central Nervous System

  2025cites this paper
• Developments in nanotechnology approaches for the treatment of solid tumors

  2025cites this paper
• Blood-Brain Barrier-Permeable, Reactive Oxygen Species-Producing, and Mitochondria-Targeting Nanosystem Amplifies Glioblastoma Therapy.

  2025cites this paper
• Nanotherapeutic strategies exploiting biological traits of cancer stem cells

  2025cites this paper
• Comprehensive review on glioblastoma: nanotechnology, immunotherapy and combined therapeutic approaches

  2025cites this paper
• Advanced nanoparticle engineering for precision therapeutics of brain diseases.

  2025cites this paper
• Metformin-encapsulating immunoliposomes conjugated with anti-TROP 2 antibody fragments for the active targeting of triple-negative breast cancer.

  2025cites this paper
• Exploring anti-integrin α6 antibody and transferrin-decorated dual drug-loaded liposomes as a promising nanoplatform for glioblastoma therapy: a preclinical approach

  2025cites this paper
• Genomic landscapes and therapeutic perspectives of cancer stem cells in the tumor microenvironment

  2025cites this paper
• A Theoretical Framework for Ligand-Functionalised Magnetic Lipid Nanoparticles in Glioblastoma Therapy

  2025cites this paper
• Nanomedicine Solutions for Alzheimer’s Disease: A Critical Review of Therapeutic Nanoparticle Strategies

  2025cites this paper
• Harnessing Regenerative Science in Aesthetic Surgery: The Biologically Driven Future

  2025cites this paper
• CRISPR/Cas9 in colorectal cancer: Revolutionizing precision oncology through genome editing and targeted therapeutics

  2025cites this paper
• Natural polysaccharides in colloidal drug delivery systems for brain glioma therapy: Mechanisms and advancements.

  2025cites this paper
• Antibody-conjugated polymer nanoparticles for brain cancer

  2025cites this paper
• Chemically engineered exogenous organic reactions in living cells for in situ fluorescence imaging and biomedical applications.

  2024cites this paper
• Recent advances in liposomes and peptide-based therapeutics for glioblastoma treatment.

  2024cites this paper
• Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment

  2024cites this paper
• Targeted Delivery of Nanomedicines to Glioblastoma: Overcoming the Clinical Barrier

  2024cites this paper
• Recent composition and applications of liposomes in cancer therapy

  2024cites this paper
• Advancements in dendrimer-based drug delivery for combinatorial cancer therapy

  2024cites this paper
• Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer

  2024cites this paper
• Overcoming brain barriers through surface-functionalized liposomes for glioblastoma therapy; current status, challenges and future perspective.

  2024cites this paper
• Promising cell systems for targeted delivery of nano- and microcarriers loaded with drugs or biomolecules (review)

  2024cites this paper
• Antibody Conjugated Nano-Enabled Drug Delivery Systems Against Brain Tumors.

  2024cites this paper
• Angiopep-2-Functionalized Lipid Cubosomes for Blood-Brain Barrier Crossing and Glioblastoma Treatment.

  2024cites this paper
• Potential of Nanocarrier-Associated Approaches for Better Therapeutic Intervention in the Management of Glioblastoma

  2024cites this paper
• Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment.

  2024cites this paper
• Optimizing Angiopep-2 Density on Polymeric Nanoparticles for Enhanced Blood-Brain Barrier Penetration and Glioblastoma Targeting: Insights from In Vitro and In Vivo Experiments

  2024cites this paper
• Nanomedicine strategies to counteract cancer stemness and chemoresistance

  2023cites this paper
• Cancer stem cells in brain tumors: From origin to clinical implications

  2023cites this paper
• Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform

  2023cites this paper
• Strategies increasing the effectiveness of temozolomide at various levels of anti-GBL therapy.

  2023cites this paper
• Glioblastoma cell-derived exosomes functionalized with peptides as efficient nanocarriers for synergistic chemotherapy of glioblastoma with improved biosafety

  2023cites this paper
• Nanoparticles for Drug and Gene Delivery in Pediatric Brain Tumors’ Cancer Stem Cells: Current Knowledge and Future Perspectives

  2023cites this paper
• Application of polymer materials in targeting glioma.

  2023cites this paper
• Nanoparticle Targeting with Antibodies in the Central Nervous System

  2023cites this paper
• Biomaterial-based Platforms for Modulating Immune Components against Cancer and Cancer Stem Cells.

  2023cites this paper
• Convection-enhanced delivery of immunomodulatory therapy for high-grade glioma

  2023cites this paper
• Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment

  2023influential citation
• Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets

  2023cites this paper
• Unleashing the Potential: Designing Antibody-Targeted Lipid Nanoparticles for Industrial Applications with CMC Considerations and Clinical Outlook.

  2023cites this paper
• Toxic warhead-armed antibody for targeted treatment of glioblastoma.

  2023cites this paper
• Functionalized liposomes: an enticing nanocarrier for management of glioma

  2023cites this paper
• Drug-Loaded Lipid Magnetic Nanoparticles for Combined Local Hyperthermia and Chemotherapy against Glioblastoma Multiforme

  2023cites this paper
• The impediments of cancer stem cells and an exploration into the nanomedical solutions for glioblastoma.

  2022cites this paper
• Homogeneous antibody–angiopep 2 conjugates for effective brain targeting

  2022cites this paper
• Liposomal-Based Formulations: A Path from Basic Research to Temozolomide Delivery Inside Glioblastoma Tissue

  2022influential citation
• Angiopep-2-Modified Nanoparticles for Brain-Directed Delivery of Therapeutics: A Review

  2022cites this paper
• Dual targeting micelles loaded with paclitaxel and lapatinib for combinational therapy of brain metastases from breast cancer

  2022cites this paper
• Combinatorial therapeutic strategies for enhanced delivery of therapeutics to brain cancer cells through nanocarriers: current trends and future perspectives

  2022cites this paper
• Nanomedicines Targeting Glioma Stem Cells.

  2022cites this paper
• Receptor-mediated cascade targeting strategies for the application to medical diagnoses and therapeutics of glioma

  2022cites this paper
• Brain-targeting drug delivery systems.

  2022cites this paper
• Biomimetic Exosomes: A New Generation of Drug Delivery System

  2022cites this paper
• An update on dual targeting strategy for cancer treatment.

  2022cites this paper
• Targeted delivery of irinotecan to colon cancer cells using epidermal growth factor receptor-conjugated liposomes

  2022cites this paper
• Phase separation in epigenetics and cancer stem cells

  2022cites this paper
• Advances in nano-based materials for glioblastoma multiforme diagnosis: A mini-review

  2022cites this paper
• Multifunctional nanocarriers for delivering siRNA and miRNA in glioblastoma therapy: advances in nanobiotechnology-based cancer therapy

  2022cites this paper
• Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?

  2022influential citation
• Neutrophil mediated drug delivery for targeted glioblastoma therapy: A comprehensive review.

  2022cites this paper
• Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases.

  2022cites this paper
• Current and Emerging Strategies for Enhancing Antibody Delivery to the Brain

  2021influential citation
• Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches

  2021cites this paper
• Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas

  2021cites this paper
• Biomimetic and cell-based nanocarriers - New strategies for brain tumor targeting.

  2021cites this paper
• An Update on Actively Targeted Liposomes in Advanced Drug Delivery to Glioma.

  2021cites this paper
• Extending the Half-Life of a Protein in Vivo by Enzymatic Labeling with Amphiphilic Lipopeptides.

  2021cites this paper
• Biomimetic Nanoscale Erythrocyte Delivery System for Enhancing Chemotherapy via Overcoming Biological Barriers.

  2021cites this paper
• Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches

  2021cites this paper
• Recent Advancements in Liposome-Targeting Strategies for the Treatment of Gliomas: A Systematic Review.

  2020cites this paper
• Liposomes modified with bio-substances for cancer treatment.

  2020cites this paper
• Cancer stem cells and strategies for targeted drug delivery

  2020cites this paper
• Nanomedicine: A Useful Tool against Glioma Stem Cells

  2020cites this paper
• Lipid-Based Nanocarriers for The Treatment of Glioblastoma

  2020cites this paper
• Antibody-Conjugated Vitamin E-Derived Liposomes for Targeted Gene Transfer.

  2020cites this paper
• Repurposing of Fluvastatin as an Anticancer Agent against Breast Cancer Stem Cells via Encapsulation in a Hyaluronan-Conjugated Liposome

  2020cites this paper
• Nanoparticle-mediated therapeutic compounds delivery to glioblastoma

  2020cites this paper
• Biomedical engineering approaches to enhance therapeutic delivery for malignant glioma.

  2020cites this paper
• Brain delivery of Plk1 inhibitor via chimaeric polypeptide polymersomes for safe and superb treatment of orthotopic glioblastoma.

  2020cites this paper
• Beyond DNA-targeting in Cancer Chemotherapy. Emerging Frontiers- A Review.

  2020cites this paper
• Potential advancements in the treatment of difficult-to-treat glioblastoma through nanoparticle drug delivery.

  2020cites this paper
• Immunoconjugates for cancer targeting: a review of antibody-drug conjugates and antibody-functionalized nanoparticles.

  2020cites this paper
• Homotypic targeting and drug delivery in glioblastoma cells through cell membrane-coated boron nitride nanotubes

  2020cites this paper
• Suppression of cancer stem cells

  2020cites this paper
• Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: nanomedicine approaches to improve their efficacy.

  2020cites this paper
• Nanotherapeutics in glioma management: Advances and future perspectives

  2020cites this paper
• Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing

  2020cites this paper
• Sequential Targeting in Crosslinking Nanotheranostics for Tackling the Multibarriers of Brain Tumors

  2020cites this paper